Denali Therapeutics Inc. (DNLI) PT Raised to $53 at Wedbush
Tweet
Share
E-mailGet Alerts DNLI Hot Sheet
Price: $23.76 -1%
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Join SI Premium – FREE
Wedbush analyst Laura Chico raised the price target on Denali Therapeutics Inc. (NASDAQ: DNLI) to $53.00 (from $50.00) while maintaining a Outperform rating.
You May Also Be Interested In
- RBC Capital Downgrades Bapcor Ltd. (BAP:AU) to Underperform
- Five9, Inc (FIVN) PT Raised to $40 at Truist Securities
- BRC Inc. (BRCC) PT Raised to $25 at DA Davidson to Adjust for Reverse Split
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
